ANIXA BIOSCIENCES, INC. Paid-in-Kind Interest
ANIXA BIOSCIENCES, INC. (ANIX) reported Paid-in-Kind Interest of $20.67 thousand for the 9-month period ending 2017-07-31, per its 10-Q filed 2018-09-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2018-09-07
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2017-07-31 was -$9.33K.
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2017-04-30 was -$24.00K.
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2017-01-31 was $54.00K.
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for the quarter ending 2014-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for fiscal 2014 was $61.78K, a 37.43% decline from fiscal 2013.
- ANIXA BIOSCIENCES, INC. paid-in-kind interest for fiscal 2013 was $98.74K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2017-07-31 | -$9.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | -$33.33K derived: sum of 2 quarters · filed 2018-09-07 | $20.67K 10-Q · filed 2018-09-07 | |
| 2017-04-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $30.00K 10-Q · filed 2017-05-26 | ||
| 2017-01-31 | $54.00K 10-Q · filed 2017-03-16 | |||
| 2014-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $0.00 derived: sum of 2 quarters · filed 2015-12-23 | $32.98K derived: sum of 3 quarters · filed 2015-12-23 | $61.78K 10-K · filed 2015-12-23 |
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $32.98K derived: sum of 2 quarters · filed 2015-08-18 | $61.78K 10-Q · filed 2015-08-18 | $90.58K derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-04-30 | $32.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $61.78K 10-Q · filed 2015-05-22 | $90.58K derived: sum of 3 quarters · filed 2015-05-22 | $125.76K derived: sum of 4 quarters · filed 2015-05-22 |
| 2014-01-31 | $28.80K 10-Q · filed 2015-03-09 | $57.60K derived: sum of 2 quarters · filed 2015-03-09 | $92.78K derived: sum of 3 quarters · filed 2015-03-09 | |
| 2013-10-31 | $28.80K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $63.98K derived: sum of 2 quarters · filed 2015-01-29 | $98.74K 10-K · filed 2015-01-29 | |
| 2013-07-31 | $35.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $69.94K 10-Q · filed 2014-09-15 | ||
| 2013-04-30 | $34.76K 10-Q · filed 2014-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |